UNIMED PHARMA, spol. s r.o.
ActiveKey figures
Key figures
2025Summary: UNIMED PHARMA, spol. s r.o.
What kind of company is it?
UNIMED PHARMA, spol. s r.o. (IČO 31367216) is a limited liability company (s.r.o.). The company was incorporated in 1994 and has existed for 32 years. Registered office according to the register: Bratislava. Main activity according to the Statistical Office: výroba farmaceutických prípravkov (SK NACE 2120). Size category by number of employees: 50–99 employees.
Who runs the company and who owns it?
The statutory body has 2 members. According to the register, the company has 2 shareholders. The registered capital is 9 959 €.
How is the company doing financially?
Revenue for 2025 was 21 155 513 €, down 5,2 % on the previous year (22 316 216 €). From 2020 to 2025, revenue grew by an average of 10,5 % per year. Net profit for 2025 was 1 461 825 € (6,9 % of revenue). The company was profitable in all 6 reported years. Personnel costs for 2025 were 4 697 038 €. At the end of 2025 the company had total assets of 36 938 101 € and equity of 24 703 852 € (equity ratio 66,9 %).
Where does the data come from and how current is it?
Company and people data come from the Register of Legal Entities (Statistical Office SR, CC BY 4.0) and financial statements from the Register of Financial Statements (Ministry of Finance SR); icoprofil.sk updates them daily. Data as of 11. 11. 2026. Changes, averages and ratios are calculated by icoprofil.sk from open data and are not an official assessment.
Summary of annual reports2020–2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Revenue (net turnover) | 14 701 328 | 16 172 871 | 18 682 879 | 22 316 216 | 21 155 513 |
| Profit for the reporting year | 1 389 798 | 561 212 | 1 367 178 | 1 445 290 | 1 461 825 |
| Retained earnings of previous periods | 18 375 970 | 19 765 767 | 20 326 979 | 21 694 158 | 23 139 447 |
| Total assets | 21 011 340 | 22 111 139 | 26 425 754 | 32 148 333 | 36 938 101 |
| Total liabilities | 1 142 962 | 1 681 520 | 4 628 985 | 8 906 274 | 12 183 798 |
| Total equity | 19 868 348 | 20 429 559 | 21 796 738 | 23 242 029 | 24 703 852 |
| Calculated dividends | 0 | 0 | 0 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Documents in the Register of Financial Statements18
- 2025 Úč POD · 12 pp.
- 2025 Úč POD
- 2024 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2024 Správa audítora
- 2024 Úč POD · 12 pp.
- 2024 Úč POD
- 2023 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2023 Správa audítora
- 2023 Úč POD · 12 pp.
- 2023 Úč POD
- 2022 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2022 Správa audítora
- 2022 Úč POD · 12 pp.
- 2022 Úč POD
- 2021 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2021 Správa audítora
- 2021 Úč POD · 12 pp.
- 2021 Úč POD
Documents open directly on registeruz.sk (Ministry of Finance of the Slovak Republic).
Similar companies
- HBM Pharma s.r.o. · Martin
- G.V.Pharma, a.s. · Hlohovec
- Pharmagal, spol. s.r.o. · Nitra
- hameln rds s. r. o. · Modra
- BEL - MIDITECH, s.r.o. · Kráľová pri Senci
- MED-PLANT, s.r.o. · Modra
- VALOVIČ, s.r.o. · Bratislava
- GALVEX, spol. s r.o. · Banská Bystrica
- PANACEA, s.r.o. · Žilina
- IMUNA PHARM, a.s. · Šarišské Michaľany